Search Results - "Deering, Raquel"
-
1
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Published in The New England journal of medicine (03-11-2016)“…Fatal autoimmune myocarditis with rhabdomyolysis and refractory arrhythmias developed in two patients treated with a combination of anti–CTLA-4 and anti–PD-1…”
Get full text
Journal Article -
2
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Published in Nature medicine (01-06-2023)“…Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T cell rich tumors fail to respond to immune checkpoint blockade…”
Get full text
Journal Article -
3
Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program
Published in The Journal of clinical investigation (01-03-2015)“…Leukemia stem cells (LSCs) are found in most aggressive myeloid diseases and contribute to therapeutic resistance. Leukemia cells exhibit a dysregulated…”
Get full text
Journal Article -
4
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Published in Expert opinion on drug delivery (01-06-2014)“…Nucleic acid-based vaccines are being developed as a means to combine the positive attributes of both live-attenuated and subunit vaccines. Viral vectors and…”
Get more information
Journal Article -
5
The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins
Published in Cell reports (Cambridge) (22-12-2015)“…Members of the Msi family of RNA-binding proteins have recently emerged as potent oncoproteins in a range of malignancies. MSI2 is highly expressed in…”
Get full text
Journal Article -
6
Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs
Published in The Journal of experimental medicine (13-01-2014)“…Hematopoietic stem cells (HSCs) are maintained through the regulation of symmetric and asymmetric cell division. We report that conditional ablation of the…”
Get full text
Journal Article -
7
Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy
Published in British journal of haematology (01-11-2022)“…Summary Outcomes remain poor for patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma (R/R B‐NHL). While chimeric antigen receptor (CAR) T‐cell…”
Get full text
Journal Article -
8
Genome-wide analyses and functional profiling of human NK cell lines
Published in Molecular immunology (01-11-2019)“…•Found 557 genes with >50-fold difference in expression between at least 2 cell lines.•NK92 cells have a CD56bright-like phenotype while YTS cells are…”
Get full text
Journal Article -
9
Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses
Published in Science (American Association for the Advancement of Science) (09-10-2009)“…Models of mammalian regulatory networks controlling gene expression have been inferred from genomic data but have largely not been validated. We present an…”
Get full text
Journal Article -
10
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells
Published in Nature genetics (01-06-2017)“…Michael Kharas and colleagues characterize the MSI2 protein interactome in leukemia cells and subsequently perform a functional screen identifying 24 genes…”
Get full text
Journal Article -
11
Rapid TCR:Epitope Ranker (RAPTER): a primary human T cell reactivity screening assay pairing epitope and TCR at single cell resolution
Published in Scientific reports (25-05-2023)“…Identifying epitopes that T cells respond to is critical for understanding T cell-mediated immunity. Traditional multimer and other single cell assays often…”
Get full text
Journal Article -
12
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Published in Journal for immunotherapy of cancer (21-03-2024)“…BackgroundPatients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL) have a significant need for effective treatment options. Odronextamab is an…”
Get full text
Journal Article -
13
IKBKG (nuclear factor-κB essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function
Published in Journal of allergy and clinical immunology (01-04-2008)“…Background Patients with hypomorphic nuclear factor-κB essential modulator ( NEMO ) mutations have extensive phenotypic variability that can include atypical…”
Get full text
Journal Article -
14
264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundTo better understand the immune stimulatory mechanisms of Oncolytic virus (OV), we evaluated the circulating OV-specific T cell response in patients…”
Get full text
Journal Article -
15
Development of a Clinical Assay To Evaluate Toll-Like Receptor Function
Published in Clinical and Vaccine Immunology (01-01-2006)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
16
Common and rare variant associations with clonal haematopoiesis phenotypes
Published in Nature (London) (08-12-2022)“…Clonal haematopoiesis involves the expansion of certain blood cell lineages and has been associated with ageing and adverse health outcomes 1 – 5 . Here we use…”
Get full text
Journal Article -
17
Abstract CT121: A phase Ib study of recombinant vaccinia virus in combination with immune checkpoint inhibition (ICI) in advanced renal cell carcinoma (RCC)
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Background: Oncolytic immunotherapy employs viruses that are designed to preferentially replicate in and lyse cancer cells and in this process trigger…”
Get full text
Journal Article -
18
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Published in The lancet. Gastroenterology & hepatology (01-03-2022)“…Surgical resection of early stage hepatocellular carcinoma is standard clinical practice; however, most tumours recur despite surgery, and no perioperative…”
Get more information
Journal Article -
19
A framework for highly multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
Published in Science advances (01-05-2021)“…T cell receptor (TCR) antigen-specific recognition is essential for the adaptive immune system. However, building a TCR-antigen interaction map has been…”
Get full text
Journal Article -
20
Author Correction: Common and rare variant associations with clonal haematopoiesis phenotypes
Published in Nature (London) (02-03-2023)Get full text
Journal Article